💨 Abstract
Scientists at King's College London are exploring a new form of immunotherapy for certain types of cancer, such as breast and ovarian cancers that express HER2. They are using a different antibody type, IgE, which activates the immune system in a unique way, stimulating otherwise inactive immune cells in the tumor's microenvironment.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
How Paatal Lok & contemporary fiction offer a window to the Northeast
Optimism on Financial Performance Declines; Industrial Sector witnesses largest drop since Q3 2023
India's Delhi airport operator sues government over flights from defence airbase
Trump says will speak with Putin on Tuesday about ending war in Ukraine
IMF has received a formal request for a new Kenya financing programme
Bright Outdoor Media Expands Its Digital LED Network in Mumbai with 3 New LED Billboards
India will drive global oil consumption growth: Phillip Capital
Gold holds steady as geopolitical and economic concerns linger
One of craziest things I've ever been part of...": Simone Ashley on working in Brad Pitt-starrer 'F1'
Modi speaking Trump's language: Cong on PM's remarks on global organisations
Powered by MessengerX.io